Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaya Imoto

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Bioscience, Biotechnology, and Biochemistry|September 25, 2018
Chemistry and biology for the small molecules targeting characteristics of cancer cellsMasaya Imoto
The Journal of Antibiotics|November 2, 2017
Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancersMasaya Imoto
Seikagaku. the Journal of Japanese Biochemical Society|July 19, 2005
[Regulation of tumor malignancy by inhibitors of posttranslational modification of Ras and Rho family proteins]Masaya Imoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 16, 2008
[Bioprobe generation from microbial origin for chemical biology study]Masaya Imoto
The Journal of Antibiotics|September 27, 2021
Approach toward molecular targeted therapy for cancer using microbial productsMasaya Imoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Metabolomics and molecular targeted therapy of cancer]Etsu Tashiro, Masaya Imoto
Bioorganic & Medicinal Chemistry|April 21, 2016
Screening and target identification of bioactive compounds that modulate cell migration and autophagyEtsu Tashiro, Masaya Imoto
The Journal of Biological Chemistry|March 20, 2003
Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashionMakoto Kawatani, Masaya Imoto
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 7, 2007
[Development of farnesyltransferase inhibitor for anti-cancer drugs]Yasushi Takemoto, Masaya Imoto
Bioorganic & Medicinal Chemistry|November 23, 2011
Target identification of bioactive compoundsEtsu Tashiro, Masaya Imoto
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Bioscience, Biotechnology, and Biochemistry|September 25, 2018
Chemistry and biology for the small molecules targeting characteristics of cancer cellsMasaya Imoto
The Journal of Antibiotics|November 2, 2017
Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancersMasaya Imoto
Seikagaku. the Journal of Japanese Biochemical Society|July 19, 2005
[Regulation of tumor malignancy by inhibitors of posttranslational modification of Ras and Rho family proteins]Masaya Imoto
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 16, 2008
[Bioprobe generation from microbial origin for chemical biology study]Masaya Imoto
The Journal of Antibiotics|September 27, 2021
Approach toward molecular targeted therapy for cancer using microbial productsMasaya Imoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Metabolomics and molecular targeted therapy of cancer]Etsu Tashiro, Masaya Imoto
Bioorganic & Medicinal Chemistry|April 21, 2016
Screening and target identification of bioactive compounds that modulate cell migration and autophagyEtsu Tashiro, Masaya Imoto
The Journal of Biological Chemistry|March 20, 2003
Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashionMakoto Kawatani, Masaya Imoto
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 7, 2007
[Development of farnesyltransferase inhibitor for anti-cancer drugs]Yasushi Takemoto, Masaya Imoto
Bioorganic & Medicinal Chemistry|November 23, 2011
Target identification of bioactive compoundsEtsu Tashiro, Masaya Imoto
Pageof 13